The clinical use of ketamine as we know it today has been a collaboration between many different fields in healthcare. Starting with researchers and pharmaceutical companies in the 1960s, ketamine…
Psychedelic substances are re-emerging as promising therapeutic agents for a wide-range of conditions. Once demonized for their mind-altering properties, research is increasingly highlighting their therapeutic potential for treating a range…
Ketamine, a medication once solely used as an anaesthetic, has emerged as a promising new option for treatment-resistant depression and potentially for other psychiatric conditions. Research suggests it can offer…
Ketamine-assisted psychotherapy (KAP) is an emerging treatment for mental health conditions like depression, anxiety, and PTSD. Currently the strongest evidence for this treatment option relates to treatment-resistant depression (TRD) and…
Currently, ketamine is used in treating multiple pain, mental health, and substance abuse disorders due to rapid-acting analgesic and antidepressant effects. Its limited short-term durability has motivated research into the…
Ketamine is a dissociative drug that has been used medically since the 1970s primarily as an anesthetic agent but also for various psychiatric applications. Anecdotal reports and clinical research suggest…
In the past two decades, subanaesthetic doses of ketamine have been demonstrated to have rapid and sustained antidepressant effects, and accumulating research has demonstrated ketamine's therapeutic effects for a range of psychiatric conditions. In light of these findings surrounding ketamine's psychotherapeutic potential, we systematically review the extant evidence on ketamine's effects in treating mental health disorders.
